Market Tracker

06/28 5:16pm ET

Endocyte Inc (NASDAQ:ECYT)

3.29
Delayed Data
As of 4:00pm ET
 +0.22 / +7.17%
Today’s Change
2.65
Today|||52-Week Range
5.87
-17.96%
Year-to-Date
No recent news for Endocyte Inc.

Today’s Trading

Previous close3.07
Today’s open3.23
Day’s range3.10 - 3.38
Volume143,171
Average volume (3 months)174,361
Market cap$129.4M
Dividend yield--
Data as of 4:00pm ET, 06/28/2016

Growth & Valuation

Earnings growth (last year)-853.85%
Earnings growth (this year)-12.45%
Earnings growth (next 5 years)--
Revenue growth (last year)-99.90%
P/E ratioNM
Price/Sales2,402.53
Price/Book0.75

Competitors

 Today’s
change
Today’s
% change
LPCNLipocine Inc-0.92-12.80%
RDHLRedhill Biopharma Lt...+0.38+3.79%
EIGREiger BioPharmaceuti...+0.27+1.48%
CRBPCorbus Pharmaceutica...+0.10+3.45%
Data as of 4:00pm ET, 06/28/2016

Financials

Next reporting dateJuly 28, 2016
EPS forecast (this quarter)-$0.26
Annual revenue (last year)$70.0K
Annual profit (last year)-$41.3M
Net profit margin-58,956.78%

Profile

Sector
Health Technology
Industry
Biotechnology
President, CEO, CFO &
Director
Michael A. Sherman
Director &
Chief Science Officer
Philip S. Low
Corporate headquarters
West Lafayette, Indiana

Forecasts